University of Washington Reading & Dyslexia Research Program

Subjects are recruited for a pre-kindergarten education program focusing on early literacy skills. Primary outcomes are improvement in letter knowledge and changes in brain response to text.

Study Overview

• Status: Unknown
• Conditions: Reading Disability
• Intervention / Treatment: Behavioral: preK

• Study Type: Observational
• Enrollment (Anticipated): 44

Contacts and Locations

• Study Contact: Name: Patrick Donnelly; Phone Number: 206-685-9365; Email: pdonne@uw.edu

Study Locations

• United States
  • Washington
    • Seattle, Washington, United States, 98195
      • Recruiting
      • University of Washignton
      • Contact: Jason Yeatman, PhD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 5 years to 6 years (Child)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Typically developing children

Description

Inclusion Criteria: Typically developing children enrolled before kindergarten.

• Typically developing child between 60 and 72 months of age
• Has not yet begun Kindergarten

Exclusion Criteria:

• Reported neurological or psychiatric condition.
• Claustrophobia. ADHD

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Letters; Education program focuses on learning letters.	Behavioral: preK; Subjects enter and education program that either focuses on learning letters and their corresponding sounds or on language comprehension skills.
Language; Education program focuses on language comprehension.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Letter Knowledge	Knowledge of letter names and sounds. This is computed as percent correct (out of 52). Each child is shown a flash card with each upper case letter and asked to name it and say its sound	Within 2 weeks post intervention

Collaborators and Investigators

• Sponsor: University of Washington
• Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
• Investigators: Principal Investigator: Jason Yeatman, PhD, University of Washington

Study record dates

Study Major Dates

• Study Start (Anticipated): May 1, 2019
• Primary Completion (Anticipated): June 1, 2021
• Study Completion (Anticipated): June 1, 2021

Study Registration Dates

• First Submitted: April 26, 2019
• First Submitted That Met QC Criteria: May 7, 2019
• First Posted (Actual): May 10, 2019

Study Record Updates

• Last Update Posted (Actual): May 10, 2019
• Last Update Submitted That Met QC Criteria: May 7, 2019
• Last Verified: May 1, 2019

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders; Nervous System Diseases; Neurologic Manifestations; Neurobehavioral Manifestations; Neurodevelopmental Disorders; Language Disorders; Communication Disorders; Learning Disabilities; Dyslexia
• Other Study ID Numbers: STUDY00000516; 1R21HD092771-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No